Gemcitabine Hydrochloride Patent Expiration

1. Gemzar patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5464826 LILLY Method of treating tumors in mammals with 2',2'-difluoronucleosides
Nov, 2012

(11 years ago)

US5464826

(Pediatric)

LILLY Method of treating tumors in mammals with 2',2'-difluoronucleosides
May, 2013

(11 years ago)




Market Authorisation Date: 15 May, 1996

Treatment: Method of treating susceptible neoplasms in mammals

Dosage: INJECTABLE

How can I launch a generic of GEMZAR before it's drug patent expiration?
More Information on Dosage

GEMZAR family patents

Family Patents

2. Infugem patent expiration

INFUGEM's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9241948 SUN PHARM Ready to be infused gemcetabine solution
Jul, 2033

(8 years from now)




Market Authorisation Date: 16 July, 2018

Treatment: NA

Dosage: SOLUTION

More Information on Dosage

INFUGEM family patents

Family Patents